Fujifilm Cellular Dynamics rolls out iCell Blood-Brain Barrier Isogenic Kit

By NS Healthcare Staff Writer

02 Jun 23

Available commercially by the end of June, the iCell Blood-Brain Barrier Isogenic Kit is an off-the-shelf, ready-to-use cell…

PharmaceuticalsDrug discovery

Artificial Intelligence System Predicts Consequences of Gene Modifications

By NS Healthcare Staff Writer

01 Jun 23

Researchers trained a computer model to understand the connections between thousands of genes—and pinpoint how those connections go…

PharmaceuticalsDrug discovery

XtalPi forges AI drug discovery collaboration worth up to $250m with Lilly

By NS Healthcare Staff Writer

31 May 23

The drug discovery partnership will make use of XtalPi’s integrated AI capabilities and robotics platform to design and…

PharmaceuticalsDrug discovery

Kiyatec, AstraZeneca partner to use KIYA-Predict for preclinical assets evaluation

By NS Healthcare Staff Writer

31 May 23

The platform enables a research strategy that uses Kiyatec's capacity to correctly dissociate and characterise primary patient tissues…

PharmaceuticalsDrug discovery

Gilead Sciences acquires California-based biotech company XinThera

By NS Healthcare Staff Writer

10 May 23

Founded in 2021, XinThera is aiming to develop small molecule drugs for the treatment of cancer and immunologic…

PharmaceuticalsDrug discovery

Alloy Therapeutics, Lundbeck partner on drug discovery for brain health

By NS Healthcare Staff Writer

03 May 23

Under the agreement, Lundbeck will have access to Alloy Therapeutics’ antibody discovery services as well as its SeqImmune…

PharmaceuticalsDrug discovery

BioNTech, Ryvu collaborate on small molecule immuno-modulatory therapies

By NS Healthcare Staff Writer

01 Dec 22

Under the collaboration, the two companies will jointly develop several small molecule programmes, primarily targeting immune modulation in…

PharmaceuticalsDrug discovery

UK announces over £800m funding to improve innovation, growth and patient safety

By NS Healthcare Staff Writer

17 Oct 22

The funding will help to generate new treatments and improve the delivery of healthcare services to support experimental…

PharmaceuticalsDrug discovery

Odyssey Therapeutics secures $168m in Series B financing round

By NS Healthcare Staff Writer

14 Oct 22

The new financing will allow Odyssey Therapeutics to advance its portfolio of precision immunomodulators and oncology medicines, supporting…

PharmaceuticalsDrug discovery

Illumina, AstraZeneca collaborate on drug target discovery

By NS Healthcare Staff Writer

12 Oct 22

The strategic research collaboration will combine Illumina and AstraZeneca’s combined strengths in artificial intelligence (AI) based genome interpretation…

PharmaceuticalsDrug discovery